Our previous identification of an ALDH1+ve CSC subpopulation in cisplatin-resistant NSCLC cell lines lead us to investigate the association of ALDH1 with the retinoic acid pathway [27]. This evidence concerns the gene ALDH1A1 and non-small cell lung carcinoma.